Elevated salivary uric acid levels among adolescents with eating disorders.


Journal

Eating and weight disorders : EWD
ISSN: 1590-1262
Titre abrégé: Eat Weight Disord
Pays: Germany
ID NLM: 9707113

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 08 07 2019
accepted: 14 10 2019
pubmed: 2 11 2019
medline: 24 6 2021
entrez: 1 11 2019
Statut: ppublish

Résumé

Uric acid (UA) is increasingly recognized as having important physiological roles and associated with several peripheral and central pathophysiological outcomes, and might play a role in eating disorders (ED) pathogenesis. We investigated whether UA levels are altered among adolescents with ED. Morning salivary UA concentrations were compared between adolescents referred to treatment at the Herman Dana Center receiving a DSM-V diagnosis of an ED and matched healthy controls. Salivary UA was significantly elevated among ED compared with control values (ED mean 3.9 ± 1.2 mg/dl, control mean 2.9 ± 1.9 mg/dl, t = - 3.13 df = 81, p = 0.003). Salivary UA is elevated among adolescents with ED. Further studies are required to replicate and extend this finding and evaluate its generalizability as a state or trait marker as regards ED subtypes, other body fluids (plasma and cerebrospinal fluid), and recovery or premorbid stages, as well as its putative mechanistic relevance to ED. Level III, case-control analytic study.

Identifiants

pubmed: 31667778
doi: 10.1007/s40519-019-00799-1
pii: 10.1007/s40519-019-00799-1
doi:

Substances chimiques

Uric Acid 268B43MJ25

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1821-1825

Auteurs

Ruth Giesser (R)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Tanya Goltser-Dubner (T)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
Molecular Psychiatry Laboratory, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Dalya Pevzner (D)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
Molecular Psychiatry Laboratory, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Amit Shalev (A)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Ranin Masarwa (R)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Laura Canetti (L)

Molecular Psychiatry Laboratory, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Ayelet Meltzer (A)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Nidal Qutna (N)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Roi Ratson (R)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Ela Kianski (E)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Shikma Keller (S)

Molecular Psychiatry Laboratory, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Esti Galili-Weisstub (E)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.

Ronen Segman (R)

Herman-Dana Division of Child and Adolescent Psychiatry, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel. ronense@ekmd.huji.ac.il.
Molecular Psychiatry Laboratory, Department of Psychiatry, Hadassah - Hebrew University Medical Center, Jerusalem, Israel. ronense@ekmd.huji.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH